These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26681266)

  • 1. Brain metabolism changes with 18F-fluorodeoxy- glucose-positron emission tomography in a patient with Cotard's syndrome.
    Ozkan N; Caliyurt O
    Aust N Z J Psychiatry; 2016 Jun; 50(6):600-1. PubMed ID: 26681266
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain dead yet mind alive: a positron emission tomography case study of brain metabolism in Cotard's syndrome.
    Charland-Verville V; Bruno MA; Bahri MA; Demertzi A; Desseilles M; Chatelle C; Vanhaudenhuyse A; Hustinx R; Bernard C; Tshibanda L; Laureys S; Zeman A
    Cortex; 2013; 49(7):1997-9. PubMed ID: 23664000
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated basal ganglia glucose metabolism in cyclosporine neurotoxicity: a positron emission tomography imaging study.
    Meyer MA
    J Neuroimaging; 2002 Jan; 12(1):92-3. PubMed ID: 11826612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotard's syndrome in a patient with schizophrenia-spectrum disorder.
    Malone GW; Fort J; Mohammad-Amin H
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36450414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of glucose metabolism in basal ganglia diagnosed with FDG-PET scan: a neuroacanthocytosis case.
    Selcuk NA; Fenercioglu A
    Clin Nucl Med; 2010 Jul; 35(7):557-8. PubMed ID: 20548161
    [No Abstract]   [Full Text] [Related]  

  • 6. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cotard's Syndrome in Three Patients with Schizophrenia--Pathology of Involutional and Senile-onset Endogenous Psychosis].
    Fuke T; Takahashi T; Yamada Y; Miyashita M; Amano N; Matsushita M
    Seishin Shinkeigaku Zasshi; 2015; 117(4):257-68. PubMed ID: 26524837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulpiride treatment of Cotard's syndrome in schizophrenia.
    Shiraishi H; Ito M; Hayashi H; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):607-9. PubMed ID: 15093970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Content-specific delusions from right caudate lacunar stroke: association with prefrontal hypometabolism.
    McMurtray AM; Sultzer DL; Monserratt L; Yeo T; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):62-7. PubMed ID: 18305285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG-PET/CT in implant-associated anaplastic large cell lymphoma of the breast.
    Acevedo-Báñez I; García-Gomez FJ; Jiménez-Granero P; Carrillo-Cruz E; Perez-Lopez O; Borrego-Dorado I
    Br J Haematol; 2015 Apr; 169(1):1. PubMed ID: 25521839
    [No Abstract]   [Full Text] [Related]  

  • 13. [Functional imaging for disorders of basal ganglia].
    Otsuka M; Taniwaki T
    Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
    Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
    Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Positron emission tomography and basal ganglia functions].
    Kato M
    No To Shinkei; 1990 May; 42(5):450-60. PubMed ID: 2206633
    [No Abstract]   [Full Text] [Related]  

  • 16. [(18) F]-Fluorodeoxyglucose positron emission tomography combined with computed tomography imaging with remission of type 2 diabetes after gastric bypass surgery.
    Pahk K; Park S; Kim S; Choe JG
    J Diabetes; 2016 Jan; 8(1):162-4. PubMed ID: 26531145
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography in Rasmussen's encephalitis.
    Shetty-Alva N; Novotny EJ; Shetty T; Kuo PH
    Pediatr Neurol; 2007 Feb; 36(2):112-4. PubMed ID: 17275663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cotard's syndrome in chronic schizophrenia].
    Kato K
    Igaku Kenkyu; 1993 May; 63(2):49-51. PubMed ID: 8279243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain atrophy and interhemispheric fissure enlargement in Cotard's syndrome.
    Joseph AB; O'Leary DH
    J Clin Psychiatry; 1986 Oct; 47(10):518-20. PubMed ID: 3759917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brain PET-FDG evolutive control of a metastatic pinealoblastoma].
    Gil Martínez EM; Ramírez López MA; Moya García F; González Cabezas P
    Rev Esp Med Nucl; 2006; 25(1):40. PubMed ID: 16540011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.